Key actions by disease
Consultations
Useful resources
/photostory/2021-waaw-viet-nam/waaw-2021-viet-nam-photo-story-7.jpg?sfvrsn=12ba95bc_7 "A technician prepares a microscopic slide in a laboratory in Hanoi, Viet Nam")
Related activities
Online learning
All →/clinical-trials-for-new-re-emerging-pathogens-gpp-module-1.tmb-549v.png?sfvrsn=6d4247d9_1)
Documents
All →
Rift Valley fever CORE protocol
Rift Valley fever (RVF) is a zoonotic viral disease caused by Rift Valley fever virus (RVFV). The virus is transmitted to humans through contact with infected...
Oropouche virus research and development roadmap
Since 2023, Oropouche disease has shown a sharp rise in cases and expanded geographical spread, accompanied by reports of neurological complications, deaths,...
WHO Technical Advisory Group – candidate vaccine prioritization: summary of the evaluations and recommendations...
To date four candidate vaccines have been evaluated at meetings that took place between 20 February and 30 March 2023, with a further meeting on 17 October...
Marburg virus – Therapeutics prioritisation
Prioritization of candidate treatments to be included in a randomized clinical trial
Publications
All →
This large, international, randomized controlled clinical trial is designed to enable an expeditious, agile and concurrent evaluation of the benefits and...
WHO R&D Blueprint COVID-19: Informal consultation on the potential inclusion of Favipiravir in a clinical...
There has been some suggestions for the inclusion of Favipiravir in the Solidarity trial.
Currently, there are no licensed vaccines for the prevention of COVID 19. While efforts continue to develop effective vaccines, it is pertinent to examine...
